News | September 24, 2007

GentleWaves Reduces Skin Inflammation, Irritation Following Radiation Treatments

September 25, 2007 - Findings in a new study, published in the February 2007 issue of Lasers in Surgery and Medicine, suggest a new way to help protect the skin during radiation therapy.

Conducted by Maitland DeLand M.D., oncologist and president of OncoLogics Inc., the study illustrates how GentleWaves LED Photomodulation, manufactured by Light BioScience, significantly reduced the incidence and degree of radiation-induced dermatitis.

Radiation therapy (RT) is a key component in the treatment of breast cancer; however, a common adverse effect associated with RT is acute radiation dermatitis. Despite modern techniques, radiation-induced dermatitis develops in an estimated 87% of breast cancer patients treated with RT. When skin reactions are severe, it may be necessary to interrupt or even stop RT permanently.

Dr. DeLand chose to experiment with the LED Photomodulation technology because it was being used by dermatologists to improve skin quality, elasticity, tone and texture. In addition, research had shown that GentleWaves is safe, non-invasive and an easy-to-use treatment that can be used on all skin types.

In the study, 47 patients each received an average of 28 radiation treatments over a 5 to 6-week period. Patients were staged before enrollment and all Fitzpatrick skin types were accepted. Patients were placed into LED and control categories on the basis of clinical data obtained by retrospective review. All patients had breast conservation surgery and histopathically proven primary breast adenocarinoma (malignant tumor) with or without lymph metastases.

Nineteen patients received GentleWaves LED Photomodulation treatment immediately after RT and for the entire period of RT. Age-matched controls were treated under identical IMRT (intensity-modulated radiation treatment) protocol without LED Photomodulation. Skin reactions were graded weekly and at the end of the final treatment to the entire breast. The number of occasions on which patients had to stop receiving RT was also recorded.

The study found that LED Photomodulation decreased the inflammation and much of the discomfort reported after radiation. After treating with GentleWaves post-radiation, none of the patients incurred moist reactions or peeled skin and only one experienced moderate erythema.

For more information:

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init